10Elms LLP’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Buy
123
+58
+89% +$59.3K 0.06% 118
2026
Q1
$59.8K Buy
65
+25
+63% +$25.3K 0.04% 192
2025
Q4
$43K Hold
40
0.04% 230
2025
Q3
$30.5K Buy
40
+10
+33% +$7.44K 0.03% 287
2025
Q2
$23.4K Hold
30
0.02% 328
2025
Q1
$24.8K Hold
30
0.02% 316
2024
Q4
$23.2K Buy
+30
New +$24.8K 0.02% 325

Other funds holding LLY

10Elms LLP's LLY Position: Q2 2026 in Review

10Elms LLP increased its Eli Lilly (LLY) stake by 89% in Q2 2026, buying an estimated $59.3K and bringing the position to 123 shares worth $148K. The position accounts for 0.06% of the portfolio, ranked #118.

10Elms LLP first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • 10Elms LLP held 123 shares of Eli Lilly worth $148K as of Q2 2026.
  • 10Elms LLP bought 58 Eli Lilly shares in Q2 2026, an estimated $59.3K.
  • Eli Lilly made up 0.06% of 10Elms LLP's portfolio in Q2 2026, its #118 holding.
  • 10Elms LLP first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 10Elms LLP's 13F filing for Q2 2026, filed 14 Aug 2026.